Estetra SRL
Records under this name other than the patents Estetra SRL holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 25 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,666,585 | Compounds and Their Uses for Alleviating Menopause-Associated Symptoms Formerly held In force · High confidence | In force | High confidence | |
| US 11,452,733 | Compounds and Their Uses for Alleviating Menopause-Associated Symptoms Lapsed on the fee record Ended Sep 27, 2026 · High confidence | Lapsed on the fee record | Ended Sep 27, 2026 | High confidence |
| US 9,987,287 | Orally disintegrating solid dosage unit containing an estetrol component Lapsed on the fee record Ended Jun 5, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jun 5, 2026 | From the USPTO record |
| US 9,884,064 | Orally disintegrating solid dosage unit containing an estetrol component Lapsed on the fee record Ended Feb 6, 2026 · From the USPTO record | Lapsed on the fee record | Ended Feb 6, 2026 | From the USPTO record |
| US 9,040,509 | Method of treating human skin and a skin care composition for use in such a method Term ended Term ended Jan 24, 2026 · From the USPTO record | Term ended | Term ended Jan 24, 2026 | From the USPTO record |
| US 7,871,995 | Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception Term ended Term ended Oct 7, 2025 · From the USPTO record | Term ended | Term ended Oct 7, 2025 | From the USPTO record |
| US 8,048,869 | Pharmaceutical composition for use in hormone replacement therapy Term ended Term ended May 14, 2025 · From the USPTO record | Term ended | Term ended May 14, 2025 | From the USPTO record |
| US 7,943,604 | Method of treating human skin and a skin care composition for use in such a method Term ended Term ended May 1, 2025 · From the USPTO record | Term ended | Term ended May 1, 2025 | From the USPTO record |
| US 7,723,320 | Use of estrogen compounds to increase libido in women Term ended Term ended Apr 23, 2025 · From the USPTO record | Term ended | Term ended Apr 23, 2025 | From the USPTO record |
| US 10,201,611 | Pharmaceutical Composition Comprising Estetrol Derivatives for Use in Cancer Therapy Term ended Term ended Apr 11, 2025 · Low confidence | Term ended | Term ended Apr 11, 2025 | Low confidence |